Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera

S. Watarai; K. Yokota; Tana; T. Kishimoto; T. Kanadani; K. Taketa; K. Oguma

doi:10.1128/JCM.39.2.798-800.2001

Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera

S. Watarai, K. Yokota, Tana, T. Kishimoto, T. Kanadani, K. Taketa, K. Oguma

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

The relationship between differential susceptibility to hemolytic-uremic syndrome (HUS) and levels of globotriaosylceramide (Gb3) in serum was studied in patients infected with verotoxin-producing Escherichia coli (VTEC). The serum Gb3 levels in patients with HUS were lower than these in diarrheal patients without subsequent HUS or in patients without clinical symptoms, indicating that individuals with a lower content of serum Gb3 show a higher incidence of HUS following VTEC infection.

Original language	English
Pages (from-to)	798-800
Number of pages	3
Journal	Journal of Clinical Microbiology
Volume	39
Issue number	2
DOIs	https://doi.org/10.1128/JCM.39.2.798-800.2001
Publication status	Published - 2001

ASJC Scopus subject areas

Microbiology (medical)

Access to Document

10.1128/JCM.39.2.798-800.2001

Cite this

@article{fbdfaeef287e423db5512ac35c7792ae,

title = "Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera",

abstract = "The relationship between differential susceptibility to hemolytic-uremic syndrome (HUS) and levels of globotriaosylceramide (Gb3) in serum was studied in patients infected with verotoxin-producing Escherichia coli (VTEC). The serum Gb3 levels in patients with HUS were lower than these in diarrheal patients without subsequent HUS or in patients without clinical symptoms, indicating that individuals with a lower content of serum Gb3 show a higher incidence of HUS following VTEC infection.",

author = "S. Watarai and K. Yokota and Tana and T. Kishimoto and T. Kanadani and K. Taketa and K. Oguma",

year = "2001",

doi = "10.1128/JCM.39.2.798-800.2001",

language = "English",

volume = "39",

pages = "798--800",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera

AU - Watarai, S.

AU - Yokota, K.

AU - Tana,

AU - Kishimoto, T.

AU - Kanadani, T.

AU - Taketa, K.

AU - Oguma, K.

PY - 2001

Y1 - 2001

N2 - The relationship between differential susceptibility to hemolytic-uremic syndrome (HUS) and levels of globotriaosylceramide (Gb3) in serum was studied in patients infected with verotoxin-producing Escherichia coli (VTEC). The serum Gb3 levels in patients with HUS were lower than these in diarrheal patients without subsequent HUS or in patients without clinical symptoms, indicating that individuals with a lower content of serum Gb3 show a higher incidence of HUS following VTEC infection.

AB - The relationship between differential susceptibility to hemolytic-uremic syndrome (HUS) and levels of globotriaosylceramide (Gb3) in serum was studied in patients infected with verotoxin-producing Escherichia coli (VTEC). The serum Gb3 levels in patients with HUS were lower than these in diarrheal patients without subsequent HUS or in patients without clinical symptoms, indicating that individuals with a lower content of serum Gb3 show a higher incidence of HUS following VTEC infection.

UR - http://www.scopus.com/inward/record.url?scp=0035126492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035126492&partnerID=8YFLogxK

U2 - 10.1128/JCM.39.2.798-800.2001

DO - 10.1128/JCM.39.2.798-800.2001

M3 - Article

C2 - 11158156

AN - SCOPUS:0035126492

VL - 39

SP - 798

EP - 800

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 2

ER -

Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this